Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 1006-1018
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.1006
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.1006
Figure 1 Ubiquitin-specific protease 21 and ZEB1 exhibited higher expression, and resulted into poor prognosis.
A: The mRNA expressions of ubiquitin-specific protease 21 (USP21) and ZEB1 were confirmed in normal tissues and colorectal cancer (CRC) tissues through real time-quantitative polymerase chain reaction (RT-qPCR); B: The correlation between USP21 and ZEB1 was verified; C: The prognosis of CRC patients with low or high USP21 (or ZEB1) was determined; D: The mRNA expressions of USP21 and ZEB1 were assessed in normal colonic epithelial cells (NCM460) and CRC cells (HCT-116, SW480, SW620, LoVo) through RT-qPCR; E: The protein expressions of USP21 and ZEB1 were assessed in normal colonic epithelial cells (NCM460) and CRC cells (HCT-116, SW480, SW620, LoVo) through western blot. bP < 0.01, cP < 0.001. USP21: Ubiquitin-specific protease 21.
- Citation: Lin JJ, Lu YC. Ubiquitin-specific protease 21 promotes tumorigenicity and stemness of colorectal cancer by deubiquitinating and stabilizing ZEB1. World J Gastrointest Oncol 2024; 16(3): 1006-1018
- URL: https://www.wjgnet.com/1948-5204/full/v16/i3/1006.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.1006